2023 International Society for Vaccines (ISV) Annual Congress, October 22-25, Lausanne, Switzerland

2023 年国际疫苗协会 (ISV) 年会，10 月 22 日至 25 日，瑞士洛桑

基本信息

批准号：
10754840
负责人：
DAVID B. WEINER
金额：
$ 0.5万
依托单位：
INTERNATIONAL SOCIETY OF VACCINES
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-08-22 至 2024-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10754840
关键词：
2019-nCoV Academia Acinetobacter baumannii Address Adjuvant African Swine Fever Virus Animal Model Antibody Affinity Antibody Response Antigens Area Award B-Lymphocyte Epitopes B-Lymphocytes Bone Marrow COVID-19 COVID-19 vaccine Cancer Vaccines Childhood Clinic Clinical Communicable Diseases Complement Complex Congresses Country Cytotoxic T-Lymphocytes Data Dedications Dengue Development Disease Emerging Communicable Diseases Ensure Epitopes Event Foundations Generations Government HIV Envelope Protein gp120 HIV-1 Health Healthcare Systems Helper-Inducer T-Lymphocyte Human Immune Immune response Immunization Programs Immunologic Memory Immunology Incidence Industry International Knowledge Lead Learning Licensing Malaria Malaria Vaccines Malignant Neoplasms Medical Memory B-Lymphocyte Mentors Messenger RNA Molecular Conformation Monoclonal Antibodies Mucosal Immunity Mucous Membrane Multi-Drug Resistance Multiple Bacterial Drug Resistance Oral Parasites Participant Persons Phenotype Plasma Cells Plasmodium falciparum Policies Postdoctoral Fellow Preparation Prize RNA vaccine Research Respiratory syncytial virus RSV F proteins Role SARS-CoV-2 infection Safety Scientist Senior Scientist Site Societies Speed Streptococcus pyogenes Structure Students Surface Antigens Switzerland System T-Lymphocyte T-cell receptor repertoire Technology Travel Vaccine Antigen Vaccine Design Vaccine Research Vaccines Variant Viral reservoir Virus Latency Virus-like particle Zoonoses cancer cell career career development chronic infection clinical development clinical implementation collaborative environment cost cost effective design doctoral student expectation fighting health care service organization improved influenzavirus insight lipid nanoparticle malaria transmission manufacture meetings member microbial microorganism mucosal vaccine neutralizing antibody next generation novel vaccines pathogen peer posters prevent programs response scale up severe COVID-19 skills structural biology symposium technology platform tissue resident memory T cell transmission blocking vaccination strategy vaccine candidate vaccine effectiveness vaccine platform vaccinology virtual volunteer

项目摘要

Project Summary / Abstract The International Society for Vaccines (ISV) is a not-for-profit membership organization founded in 1992 with members from 44 countries, holding annual congresses since 2007. With the ISV Annual Congress, attended by member and non-member participants from 5 continents, the Society aims to highlight the very latest ground-breaking developments in vaccine research, manufacturing, clinical development and implementation, and safety. Plenary sessions are devoted to current hot topics spanning diverse areas of vaccinology, including vaccines against challenging targets, T-cell based vaccines, B cell memory establishment, structure-based vaccine design, mucosal vaccines, and vaccines against emerging infectious diseases. The ISV Congress, as the main comprehensive non-commercial vaccine meeting, strives to ensure participation of speakers and delegates from a diverse background (academic, industry, government, and foundations). Breakout sessions include topics related to adjuvant mechanisms, One Health, vaccines against zoonotic infections, and next generation vaccines. Renowned invited speakers in these fields have been and will be invited to set the stage for each of the plenary topics, complemented with oral presentations selected from the submitted abstracts. The program will also provide a forum for the next generation of scientists who are active in the vaccinology field, to present their data in oral or poster presentations, discuss with peers and senior scientists, and advance their careers, be it in academia, industry, or government. ISV’s Bright Sparks in Vaccinology competition acknowledges student and postdoc presentations in parallel sessions of the oral program to support the participation and careers of next generation vaccinologists. To strengthen their professional advancements, the ISV Congress, building on its long-standing commitment to mentoring, dedicate a session to career development opportunities, bringing together junior and senior scientists in an interactive atmosphere. To stimulate the participation of young scientists, which has always been successful in the past, the ISV has a policy of inexpensive registration rates for PhD students and provides Travel Awards to selected junior scientists (based upon abstract submission and review for quality) to help defray costs of in-person and virtual participation. Prizes for best presentations or oral abstracts and poster abstracts are a high priority of the ISV Officers, who volunteer to review and rank all presentations during the ongoing conference to select winners and runners up based on abstract quality and presentation skills, and present award certificates to the prize winners.

项目摘要 /摘要国际疫苗学会（ISV）是建立的非营利会员组织 1992年，有来自44个国家的成员，自2007年以来举行年度国会。年度国会，来自5大洲的成员和非成员参与者参加社会旨在强调疫苗研究中最新的开创性发展，制造，临床开发和实施以及安全。全体会议是致力于跨越疫苗学的潜水区域的当前热门话题，包括疫苗具有挑战性的靶标，基于T细胞的疫苗，B细胞记忆建立，基于结构的疫苗疫苗设计，粘膜疫苗和针对新兴传染病的疫苗。 ISV 国会作为主要的综合非商业疫苗会议，努力确保来自潜水员背景的演讲者和代表的参与（学术，行业，政府和基金会）。突破性会议包括与调整有关的主题机理，一种健康，针对人畜共患感染的疫苗和下一代疫苗。这些领域的著名邀请发言人已经并且将被邀请为每个全体主题，完成了从已提交的口头演示文稿摘要。该计划还将为下一代科学家提供一个论坛活跃于疫苗学领域，以口头或海报演示介绍其数据，与同伴和高级科学家，并在学术界，工业或政府。 ISV在疫苗学竞赛中的明亮火花感谢学生和博士后在口头计划的并行会议上演讲，以支持参与和职业下一代疫苗科学家。为了加强其专业进步，ISV 国会以其长期致力于心理的承诺，致力于职业开发机会，将初级和高级科学家汇集在一起气氛。刺激年轻科学家的参与，这一直是过去，ISV成功地制定了博士生廉价注册率的政策并为选定的初级科学家提供旅行奖（基于抽象提交和审查质量），以帮助支付面对面和虚拟参与的费用。最好的奖品演讲或口头摘要和海报摘要是ISV官员的高优先事项志愿者在正在进行的会议期间审查和排名所有演讲，以选择获奖者基于抽象质量和演示技巧和颁发奖励证书，亚军给获奖者。